Question · asked by 1 review
PIMOZIDE + ANY ANTIPSYCHOTIC vs ANTIPSYCHOTIC + ANTIPSYCHOTIC: Quality of life (medium term: 12 months)
- Population
- patients with schizophrenia or related psychoses
- Intervention
- PIMOZIDE + ANY ANTIPSYCHOTIC
- Comparison
- ANTIPSYCHOTIC + ANTIPSYCHOTIC
- Outcome
- Quality of life (medium term: 12 months)
The review found no eligible studies for this question.
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
PIMOZIDE + ANY ANTIPSYCHOTIC vs ANTIPSYCHOTIC + ANTIPSYCHOTIC Quality of life: average change score medium term (3‐12 months) not reported · patients with schizophrenia or related psychoses The review found no eligible studies for this question. Pimozide for schizophrenia or related psychoses (2013) · Cochrane Headline outcomes only | no estimate extracted | Not reported | No studies found |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Pimozide for schizophrenia or related psychoses 2013 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.